The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family members from future lawsuits.

The deal, agreed to by Purdue Pharma, the Sackler family members who own the company ... every time someone got hooked — getting rich with no regard to the toll their drugs were taking on people, ...

Purdue Pharma will pay more than $7 billion for the corporation's ... the settlement in addressing the commonwealth's public health crisis. "Dependency on the drug ruined countless lives, while the ...

Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.

Purdue has sold a Narcan alternative since 2022 and Hikma has developed an opioid antagonist twice the dose of Narcan.

The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...

Sen. Mike Yakawich's bill to prohibit the state from buying overdose reversal drugs from companies that settled with states ...